Ashu Tyagi

Ashu Tyagi is a partner at Scopia Capital Management LP, based in New York, NY. In his current role, he is responsible for investment management activities, portfolio oversight, and strategic leadership within the firm, which is recognized for its fundamental research-driven approach to asset management. His leadership is notable in guiding investment strategies as well as representing Scopia Capital on the boards of several companies, including Y-mAbs Therapeutics Inc, where he has served as a director.

His investment focus centers on the healthcare and biotechnology sectors, as evidenced by his board membership at Y-mAbs Therapeutics, a clinical-stage biopharmaceutical company. During his tenure at Scopia Capital, Ashu Tyagi has specialized in public equities within the life sciences space, leveraging deep industry expertise to identify value and drive performance in portfolios targeting innovative medical and therapeutic solutions.

Prior to his current role, Dr. Tyagi—whose full name is Ashutosh Tyagi, M.D.—joined Scopia Capital after earning medical credentials, enhancing his unique position at the intersection of clinical expertise and healthcare investing. He has made significant contributions to advancing investments in the biotech sector, notably through his directorships and by fostering the growth of emerging therapeutic companies. His blend of medical and financial expertise distinguishes him in healthcare private and public market investing.